Follow-up of genetic linkage findings on chromosome 16p13: Evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD

Molecular Psychiatry

Volumn 9, Issue 2, 2004, Pages 169-173

  Turic, D ^a   Langley, K ^a   Mills, S ^a   Stephens, M ^a   Lawson, D ^a   Govan, C ^a   Williams, N ^a   Van Den Bree, M ^a   Craddock, N ^b   Kent, L ^b   Owen, M ^a   O'Donovan, M ^a   Thapar, A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; Genetics; NMDA2A

Indexed keywords

GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHROMOSOME 16P; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FUNCTION; GENE MAPPING; GENE REPLICATION; GENETIC CODE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GRIN2A GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINKAGE (GENETICS); MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 10744219774     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001387     Document Type: Article

References (25)

1. Nakanishi S, Nakajima Y, Masu M, Ueda Y, Nakahara K, Watanabe D et al. Glutamate receptors: brain function and signal transduction. Brain Res Brain Res Rev 1998; 26: 230-235.
2. Williams NM, Bowen T, Spurlock G, Norton N, Williams NJ, Hoogendoorn B et al. Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate structure. Mol Psychiatry 2002; 7: 508-514.
3. Melzer H, Gatward R, Ford T. Mental Health of Children and Adolescents in Great Britain. The Stationery Office: London, 2000.
4. Barkley RA. Attention-Deficit Hyperactivity Disorder, 2nd edn. The Guilford Press: New York, 1998.
5. Thapar A. Attention deficit hyperactivity disorder: new genetic findings, new directions. In: Behavioural Genetics in the Post-genomic Era. Plomin R, DeFries J, Craig I, McGuffin P (eds) APA, 2002.
6. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 2002; 70: 1183-1196.
7. Carlsson ML. On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions. Acta Psych Scand 2000; 102: 401-413.
8. Gainetdinov RR, Mohn AR, Bohn LM, Caron MG. Glutamate modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci USA 2001; 98: 11047-11054.
9. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999; 98: 427-436.
10. Ikeda K, Araki K, Takayama C, Inoue Y, Yagi T, Aizawa S et al. Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel. Brain Results Mol Brain Resol 1995; 33: 61-71.
11. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 1995; 373: 151-155.
12. Smalley SL, Kustanovich V, Minassian SL, Stone JL, Ogdie MN, McGough JJ et al. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet 2002; 71: 959-963.
13. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL et al. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 2000; 5: 523-530.
14. Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism screening questionnaire: diagnostic validity. Br J Psychiatry 1999; 175: 444-451.
15. Norton N, Kirov G, Krawczak M, Williams NM, O'Donovan M, Owen M. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum Genet 2002; 110: 471-478.
16. Chen X, Levine L, Kwok PY. Fluorescence polarization in homogenous nucleic acid analysis. Genome Res 1999; 9: 492-498.
17. Clayton D. A generalization of the transmission/disequilibrium test for uncertain haplotype transmission. Am J Hum Genet 1999; 65: 1170-1177.
18. Castellanos FX. Neuroimaging studies of ADHD. In: Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. Solanto M, Arnsten A, Castellanos F (eds). Oxford University Press: Oxford, 2001, pp 243-258.
19. Rubia K, Taylor E, Smith AB, Oksannen H, Overmeyer S, Newman S. Neuropsychological analyses of impulsiveness in childhood hyperactivity. Br J Psychiatry 2001; 179: 138-143.
20. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288: 1740-1748.
21. Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for Schizophrenia and Parkinsons-disease. Trends Neurosci 1990; 13: 272-276.
22. Grace AA. Psychostimulant actions on dopamine and limbic system function: relevance to the pathophysical and treatment of ADHD. In: Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. Solanto M, Arnsten A, Castellanos F (eds). Oxford University Press: Oxford, 2001, pp 134-157.
23. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163-175.
24. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223-228.
25. Bray NJ, Buckland P, Owen MJ, O'Donovan MC. Cis-acting mechanisms affect the expression of a high proportion of genes in human brain, submitted.